Pulse Biosciences
PLSE
73 hedge funds and large institutions have $104M invested in Pulse Biosciences in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 12 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
86% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $941K
6% more capital invested
Capital invested by funds: $98.4M → $104M (+$5.47M)
1% more funds holding
Funds holding: 72 → 73 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0.54% more ownership
Funds ownership: 9.16% → 9.7% (+0.54%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$3.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.65M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$575K |
| 4 |
BlackRock
New York
|
+$391K |
| 5 |
Norges Bank
Oslo,
Norway
|
+$353K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.09M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.03M |
| 3 |
Renaissance Technologies
New York
|
-$400K |
| 4 |
GAM
Griffin Asset Management
New York
|
-$351K |
| 5 |
Squarepoint
New York
|
-$285K |
PLSE Hedge Fund Activity: Q4 2024 in Review
73 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2024, worth a combined $104M — up 5.6% from $98.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PLSE positions and 12 closed out — a net gain of 1 holder — while 32 added to existing stakes and 16 trimmed.
The largest buyer was Invesco, adding an estimated $3.6M. The largest seller was Millennium Management, exiting entirely with an estimated $1.09M sold.
- 73 institutional investors held Pulse Biosciences (PLSE) as of Q4 2024, up from 72 in Q3 2024.
- Funds reported $104M of Pulse Biosciences stock for Q4 2024, up 5.6% quarter-over-quarter.
- 13 funds opened new Pulse Biosciences positions in Q4 2024 and 12 closed out, a net change of +1 holder.
- The largest Pulse Biosciences buyer in Q4 2024 was Invesco, an estimated $3.6M added.
- The largest Pulse Biosciences seller in Q4 2024 was Millennium Management, an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2024.